articleNew England Journal of MedicineJun 14, 2006BRONZE OA

Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

Beth Israel Deaconess Medical Center · Harvard University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Insulin resistance has a causal role in type 2 diabetes. Serum levels of retinol-binding protein 4 (RBP4), a protein secreted by adipocytes, are increased in insulin-resistant states. Experiments in mice suggest that elevated RBP4 levels cause insulin resistance. We sought to determine whether serum RBP4 levels correlate with insulin resistance and change after an intervention that improves insulin sensitivity. We also determined whether elevated serum RBP4 levels are associated with reduced expression of glucose transporter 4 (GLUT4) in adipocytes, an early pathological feature of insulin resistance.

Methods

We measured serum RBP4, insulin resistance, and components of the metabolic syndrome in three groups of subjects. Measurements were repeated after exercise training in one group. GLUT4 protein was measured in isolated adipocytes.

Citation impact

1,306
total citations
FWCI
47.57
Percentile
100%
References
34
Citations per year

Authors

11

Topics & keywords

Keywords
  • Retinol binding protein 4
  • Insulin resistance
  • Internal medicine
  • Endocrinology
  • GLUT4
  • Medicine
  • Insulin
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.